In letter to the editor, Lancet is criticized by a representative of the Biotechnology Industry Organization for placing politics and tabloid sensationalism above its responsibility to report and assess new science.
USA: Center for Science in the Public Interest, Washington, D.C.
Location:
Agricultural Communications Documentation Center, Funk Library, University of Illinois Box: 143 Document Number: C22045
Notes:
13 pages., "While the biopharm industry pushes forward toward commercialization, USDA has kept the public and interested stakeholders in the dark about this reemergence (of approved applications for genetic engineering of plants to produce pharmaceuticals, industrial compounds and other novel proteins).
